Matches in Wikidata for { <http://www.wikidata.org/entity/Q85953741> ?p ?o ?g. }
Showing items 1 to 70 of
70
with 100 items per page.
- Q85953741 description "artículu científicu espublizáu n'agostu de 2015" @default.
- Q85953741 description "im August 2015 veröffentlichter wissenschaftlicher Artikel" @default.
- Q85953741 description "scientific article published on 08 August 2015" @default.
- Q85953741 description "wetenschappelijk artikel" @default.
- Q85953741 description "наукова стаття, опублікована в серпні 2015" @default.
- Q85953741 name "Design and synthesis of N-[6-(Substituted Aminoethylideneamino)-2-Hydroxyindan-1-yl]arylamides as selective and potent muscarinic M₁ agonists" @default.
- Q85953741 name "Design and synthesis of N-[6-(Substituted Aminoethylideneamino)-2-Hydroxyindan-1-yl]arylamides as selective and potent muscarinic M₁ agonists" @default.
- Q85953741 type Item @default.
- Q85953741 label "Design and synthesis of N-[6-(Substituted Aminoethylideneamino)-2-Hydroxyindan-1-yl]arylamides as selective and potent muscarinic M₁ agonists" @default.
- Q85953741 label "Design and synthesis of N-[6-(Substituted Aminoethylideneamino)-2-Hydroxyindan-1-yl]arylamides as selective and potent muscarinic M₁ agonists" @default.
- Q85953741 prefLabel "Design and synthesis of N-[6-(Substituted Aminoethylideneamino)-2-Hydroxyindan-1-yl]arylamides as selective and potent muscarinic M₁ agonists" @default.
- Q85953741 prefLabel "Design and synthesis of N-[6-(Substituted Aminoethylideneamino)-2-Hydroxyindan-1-yl]arylamides as selective and potent muscarinic M₁ agonists" @default.
- Q85953741 P1433 Q85953741-A69B3D17-2AAD-4725-95E3-BCDF017635CA @default.
- Q85953741 P1476 Q85953741-6EAF7C93-96CB-48D6-AC0F-1E064457D51B @default.
- Q85953741 P2093 Q85953741-0C0C311A-6EBC-453B-B994-DD02B9CBAFD8 @default.
- Q85953741 P2093 Q85953741-11F57E92-C0BB-4694-ACF4-F0DF7CCF0F4E @default.
- Q85953741 P2093 Q85953741-4D4C7754-4C3F-4FE0-ADA5-0A92B9E7EA39 @default.
- Q85953741 P2093 Q85953741-4FD65D07-490B-47ED-B079-92D9E68D0EB0 @default.
- Q85953741 P2093 Q85953741-676216B0-BB6E-43EB-8184-F1A2F7B01A23 @default.
- Q85953741 P2093 Q85953741-6DA6C271-7305-4514-8548-C7967F954D7D @default.
- Q85953741 P2093 Q85953741-79C7BDDD-3F0F-4996-B48D-B15055048DAE @default.
- Q85953741 P2093 Q85953741-8F814EA3-85BB-464A-943B-31C614788670 @default.
- Q85953741 P2093 Q85953741-9101D949-8809-4886-9C31-63C99356BFBF @default.
- Q85953741 P2093 Q85953741-99CE53A9-1273-4870-80D3-19DCA7F176C8 @default.
- Q85953741 P2093 Q85953741-A1047085-D6E0-4D62-BC7C-3837773668CE @default.
- Q85953741 P2093 Q85953741-A3B19340-6827-41D9-B248-48ABC152B2AB @default.
- Q85953741 P2093 Q85953741-A7396DE8-7770-40B9-A87A-718B1422126B @default.
- Q85953741 P2093 Q85953741-AF5E2541-4E9A-41CF-9C6B-CF3C6255346D @default.
- Q85953741 P2093 Q85953741-B1B6CD3A-82FD-4024-B328-1AF9473B224C @default.
- Q85953741 P2093 Q85953741-BD8EFF81-834B-4570-9FB4-D6E57645F85F @default.
- Q85953741 P2093 Q85953741-F59A99B5-3D03-4FA9-A23F-176F3CE84166 @default.
- Q85953741 P2093 Q85953741-F7FACF07-4EBB-4FD1-B6DE-86682DF9C11B @default.
- Q85953741 P2860 Q85953741-4FEF35AB-BE93-4F39-9A16-918135474C88 @default.
- Q85953741 P304 Q85953741-CAB55BA3-2FBB-46F6-98EE-5B85493924D8 @default.
- Q85953741 P31 Q85953741-D11B952A-3806-4E8F-BEB6-E3390EEEF67C @default.
- Q85953741 P356 Q85953741-3B9C0E54-83ED-43F9-B542-439A4CCA668B @default.
- Q85953741 P433 Q85953741-32EACB62-2497-4BBC-AB3F-A98C73789225 @default.
- Q85953741 P478 Q85953741-21A103DD-4BD4-4BED-926A-1B5A9599EF44 @default.
- Q85953741 P577 Q85953741-CF3FB97E-DB0F-4A4B-B205-15D5B20387D9 @default.
- Q85953741 P698 Q85953741-B59A2143-2F12-4E74-BA13-1051D391F8B1 @default.
- Q85953741 P356 J.BMCL.2015.08.011 @default.
- Q85953741 P698 26299349 @default.
- Q85953741 P1433 Q2709483 @default.
- Q85953741 P1476 "Design and synthesis of N-[6-(Substituted Aminoethylideneamino)-2-Hydroxyindan-1-yl]arylamides as selective and potent muscarinic M₁ agonists" @default.
- Q85953741 P2093 "Bin Liu" @default.
- Q85953741 P2093 "Carrie H Croy" @default.
- Q85953741 P2093 "Christian C Felder" @default.
- Q85953741 P2093 "David Evans" @default.
- Q85953741 P2093 "David L McKinzie" @default.
- Q85953741 P2093 "Fese M Okha-Mokube" @default.
- Q85953741 P2093 "Frank Bymaster" @default.
- Q85953741 P2093 "G Stuart Gregory" @default.
- Q85953741 P2093 "James A Jamison" @default.
- Q85953741 P2093 "Jennifer R Allen" @default.
- Q85953741 P2093 "Mark G Bures" @default.
- Q85953741 P2093 "Marla Leigh Watt" @default.
- Q85953741 P2093 "Marvin M Hansen" @default.
- Q85953741 P2093 "Paul J Hoogestraat" @default.
- Q85953741 P2093 "Robert E Stratford" @default.
- Q85953741 P2093 "Stephen A Hitchcock" @default.
- Q85953741 P2093 "William Turner" @default.
- Q85953741 P2093 "Zhigang Rao" @default.
- Q85953741 P2860 Q24308061 @default.
- Q85953741 P304 "4158-4163" @default.
- Q85953741 P31 Q13442814 @default.
- Q85953741 P356 "10.1016/J.BMCL.2015.08.011" @default.
- Q85953741 P433 "19" @default.
- Q85953741 P478 "25" @default.
- Q85953741 P577 "2015-08-08T00:00:00Z" @default.
- Q85953741 P698 "26299349" @default.